官方服务：
资源简介：
Heart Failure, DITPA and Captopril
应用场景：
创建时间：
2010-07-01
相关数据集
DOM FIGURE S1 Supplementary data for studies in Figure 3.
A,B. Body weights of the 1-wk study (Fig. 3A-D). C. Body weights for the 4-week and 8-week study (Fig. 3E-L). D. Liver gene expression of 1-wk treatment with PF-04991532. E-G. Plasma insulin of drug t
DataCite Commons2020-06-25 更新70
Adjusted HRs of death in subpopulations treated with statin.
Adjusted HRs of death in subpopulations treated with statin.
NIAID Data Ecosystem40
Changes in body weight in the different groups (*p < 0.05).
D0: start of the treatment. D7: 8th day of treatment. D15: 16th day of treatment. D21: 22h day of treatment. D29: 30th day of treatment. Changes in body weight in the different groups (*p < 0.05).
NIAID Data Ecosystem30
MOESM4 of Rationale and design of a randomized trial to test the safety and non-inferiority of canagliflozin in patients with diabetes with chronic heart failure: the CANDLE trial
Additional file 4. Â Trial organization.
Figshare2016-12-15 更新60
Second-line treatment of metastatic colorectal cancer with HR070803 in combination with 5-FU/LV and BP102
Interventions: experimental group:HR0708035, FU/LV and BP102 Primary outcome(s): Objective response rate Study Design: Single arm
NIAID Data Ecosystem40
